8-methoxypsoralen and neurological disorders: From dysosmia to migraine

Photodermatology Photoimmunology and Photomedicine

Volumn 22, Issue 4, 2006, Pages 217-218

  Vernassière, Corinne ^a   Petitpain, Nadine ^b   Martin, Samuel ^a   Tréchot, Philippe ^b   Barbaud, Annick ^a   Schmutz, Jean Luc ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL; DIFLUCORTOLONE; METHOXSALEN;

ADULT; BLURRED VISION; CASE REPORT; CONFUSION; DIZZINESS; DRUG WITHDRAWAL; EPISTAXIS; HEADACHE; HUMAN; KERATOSIS PALMOPLANTARIS; LETTER; MALE; MIGRAINE; NEUROLOGIC DISEASE; PHOTOCHEMOTHERAPY; POMPHOLYX; PRIORITY JOURNAL; PUVA; SMELLING DISORDER; VISUAL FIELD DEFECT;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; METHOXSALEN; MIGRAINE DISORDERS; OLFACTION DISORDERS;

EID: 33746257101     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2006.00237.x     Document Type: Letter

References (6)

1. Martin S, Petitpain N, Trechot P, Barbaud A, Schmutz J-L. 8-Methoxypsoralen-induced dysosmia. Photodermatol Photoimmunol Photomed 2003; 114: 213-214.
2. Sweetman SC, ed. Martindale: The complete drug reference, 44th edition. London: Pharmaceutical Press, 2005; 1152.
3. Snyder RD, Drummond PD. Olfaction in migraine. Cephalalgia 1997; 17: 729-732.
4. Kelman L. Osmophobia and taste abnormality in migraineurs: A tertiary care study. Headache 2004; 44: 1019-1023.
5. Sperber AD, Abarbanel JM. Migraine-induced epistaxis. Headache 1986; 26: 517-518.
6. Fenton DA, Wilkinson JD. Dose-related visual-field defects in patients receiving PUVA therapy. Lancet 1983; 1: 1106.